We specialize in the evaluation and treatment of patients referred for blood and marrow stem cell transplants. Diseases treated:

Adult inherited immunodeficiencies
Essential thrombocytosis (ET)
Leukemia (acute and chronic)
Lymphoma (Hodgkin and non-Hodgkin)
Multiple myeloma
Myelodysplastic syndromes (MDS)
Myelofibrosis
Myeloproliferative neoplasms
Paroxysmal nocturnal hemoglobinuria (PNH)
Primary amyloidosis
Severe anaplastic anemia (SAA)
Sickle cell disease/anemia
- For patients with sickle cell and an available donor, doctors might recommend a transplant if the patient has one of the following:
  - More than three severe pain crises within two years
  - A stroke or silent stroke
  - Acute chest syndrome two or more times in the last two years
  - Eight or more red blood cell transfusions per year
  - Pulmonary hypertension
  - Chronic pain lasting longer than six months
  - Ultrasounds that show a high risk for having a stroke
  - Other severe complications of sickle cell

Testicular cancer
Waldenström’s macroglobulinemia
Other hematologic diseases

Moffitt Cancer Center is a high-volume center, delivering more FDA-approved CAR T cell products than any other center in the nation. Current indications for CAR T cells are for patients with relapsed or refractory blood cancers, including: